Global Quadrivalent Flu Vaccine Market Size By Type (Intradermal Shot, Intramuscular Injection, Nasal Spray), By Distribution Channel (Hospital And Pharmacy, Government Supplier), By Geographic Scope And Forecast

Quadrivalent Flu Vaccine Market Size And Forecast

Quadrivalent Flu Vaccine Market size was valued at USD 6.72 Billion in 2021 and is projected to reach USD 13.88 Billion by 2030, growing at a CAGR of 8.84% from 2023 to 2030.

A number of factors influence the increased market value, including increased public awareness of the disease, funding, and the fear of a flu pandemic. The market is expanding rapidly due to the increase in new target populations in underdeveloped and developing economies. Various biotech companies are constantly improving current vaccines by increasing their protection rate and introducing market advancements. A rise in the number of health care facilities, such as hospitals and clinics, is expected to have a positive impact on the market. The Global Quadrivalent Flu Vaccine Market report provides a holistic evaluation of the market. The report thoroughly analyzes important segments, trends, drivers, restraints, competitive landscape, and factors that play a substantial role in the market.

Global Quadrivalent Flu Vaccine Market Definition

Currently, The circulating viruses that cause annual seasonal influenza epidemics belong to two influenzas A subtypes, namely (H1N1 and H3N2), as well as two antigenically distinct type B lineages, namely (Yamagata and Victoria lineages). Diseases caused by the influenza B virus, like those caused by the influenza A virus, can be fatal and should be avoided. Until now, the vaccines used to prevent seasonal influenza were trivalent, systematically targeting viruses belonging to both A subtypes and to one or other of the B lineages.

The protective efficacy of trivalent vaccines is diminished during the seasons when viruses belonging to both B lineages co-circulated or when the circulating dominant type B virus pertained to a different lineage than the one targeted by the vaccine strain. Quadrivalent vaccines improve antigenic concordance between circulating and vaccine type B strains by targeting viruses from both B lineages. It is expected that by providing broader protection, these quadrivalent influenza vaccines will improve vaccine efficacy, public confidence in immunization, health professional satisfaction, and, inevitably, help to complete immunization coverage.

Global Quadrivalent Flu Vaccine Market Overview

The quadrivalent segment is expected to grow during the forecast period, owing to the availability of quadrivalent flu vaccines in hospitals due to their low cost. Furthermore, these vaccines are intended to provide enhanced protection against four viral strains, namely two influenzas A strains, H1N1 and H3N2, and two influenza B strains, Victoria and Yamagata. The rising prevalence of infectious disease in countries worldwide has raised an alarming situation demanding increased focus on vaccine supply by international health organizations to Quadrivalent Flu Vaccine Market growth.

Another crucial factor driving global market growth is the increasing government initiatives to promote the vaccination of the population. Furthermore, rising investment and government funding have boosted R&D in this field expected to drive market growth. However, the factor limiting the growth of the market is the high cost associated with per vaccine. This makes it difficult for a major chunk of people to afford the vaccination and thereby limiting the market growth during the forecasted period. Also, the production and supply of these vaccines have been affected by ongoing COVID 19 is a challenging issue.

Nonetheless, government initiatives to promote vaccination among the population are expected to create opportunities for the development of the market. Moreover, ongoing R&D will lead to the development of new vaccines and the improvement of current vaccines is a major cause for the rise of the Quadrivalent Flu Vaccine Market.

Global Quadrivalent Flu Vaccine MarketSegmentation Analysis

The Global Quadrivalent Flu Vaccine Market is Segmented on the basis of Type, Distribution Channel, And Geography.

Quadrivalent Flu Vaccine Market, By Type

• Intradermal Shot
• Intramuscular Injection
• Nasal Spray

Based on Type, the market is classified into Intradermal Shot, Intramuscular Injection, and Nasal Spray. Intramuscular Quadrivalent Flu Vaccine accounted for the highest market share and is anticipated to dominate the market during the forecast period. Due to its availability for babies 6 months and older. It is considered to be safer than the nasal vaccine for a broader age range.

Quadrivalent Flu Vaccine Market, By Distribution Channel

• Hospital and pharmacy
• Government supplier
• Others

Based on the Distribution Channel, the market is divided into hospitals and pharmacies, Government suppliers, and others. The hospital and pharmacy segment held the largest market share. Because vaccination is generally preferred and performed in hospitals, it is expected to generate a large market share.

Quadrivalent Flu Vaccine Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the world

On the basis of regional analysis, the Global Quadrivalent Flu Vaccine Market is classified into North America, Europe, Asia Pacific, and the Rest of the world. North America accounted for the highest market share in the Global Quadrivalent Flu Vaccine Market. The rapid development of effective vaccines and exponential technological advancement are driving market growth in this region. Whereas, the Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period due to rising population and increasing demand for effective vaccines.

Key Players

The “Global Quadrivalent Flu Vaccine Market” study report will provide valuable insight with an emphasis on the global market including some of the major players such as AstraZeneca, Serum Institute of India, Sanofi S.A., Abbott Laboratories, GlaxoSmithKline, CSL Limited, Bharat Biotech, Seqirus, Hualan Biological Engineering Inc., Mitsubishi Tanabe Pharma, and Mylan NV. The competitive landscape section includes key development strategies, market share analysis, and market positioning analysis of the aforementioned competitors internationally. Our market analysis includes a section specifically dedicated to large firms, where our analysts give an overview of each player’s financial statements, product benchmarking, and SWOT analysis.

Key Developments

Product Launches and Product Expansions

• CSL announced in February 2020 that AUDENZ vaccine can be used against the virus H5N1 Influenza A will be launched on the commercial market.
• A new inactivated quadrivalent influenza vaccine was launched in February 2020 by Abbott.

Report Scope

Top Trending Reports

Research Methodology of Market Research

To know more about the Research Methodology and other aspects of the research study, kindly get in touch with our .

Reasons to Purchase this Report

• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors• Provision of market value (USD Billion) data for each segment and sub-segment• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions and acquisitions in the past five years of companies profiled• Extensive company profiles comprising of company overview, company insights, product benchmarking and SWOT analysis for the major market players• The current as well as future market outlook of the industry with respect to recent developments (which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions• Includes an in-depth analysis of the market from various perspectives through Porter’s five forces analysis• Provides insight into the market through Value Chain• Market dynamics scenario, along with growth opportunities of the market in the years to come• 6-month post-sales analyst support

Customization of the Report

• In case of any please connect with our sales team, who will ensure that your requirements are met.